Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1969 1
1970 2
1975 1
1980 2
1981 2
1990 1
1991 1
1992 1
1994 2
1997 2
1998 1
1999 1
2000 1
2001 3
2002 5
2003 3
2004 1
2005 3
2006 4
2007 2
2008 2
2009 6
2010 3
2011 5
2012 9
2013 8
2014 10
2015 6
2016 11
2017 10
2018 14
2019 10
2020 16
2021 18
2022 19
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Contemporary Approaches to the Management of Post-stroke Apraxia of Speech.
Basilakos A. Basilakos A. Semin Speech Lang. 2018 Feb;39(1):25-36. doi: 10.1055/s-0037-1608853. Epub 2018 Jan 22. Semin Speech Lang. 2018. PMID: 29359303 Free PMC article. Review.
In the acute stage of stroke recovery, AOS following unilateral (typically) left hemisphere stroke can occur alongside dysarthria, an impairment in speech execution and control, and/or aphasia, a higher-level impairment in language function. ...This poses a challenge for s …
In the acute stage of stroke recovery, AOS following unilateral (typically) left hemisphere stroke can occur alongside dysarthria, an …
Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches.
Dashtipour K, Tafreshi A, Lee J, Crawley B. Dashtipour K, et al. Neurodegener Dis Manag. 2018 Oct;8(5):337-348. doi: 10.2217/nmt-2018-0021. Epub 2018 Sep 18. Neurodegener Dis Manag. 2018. PMID: 30223711 Review.
Treatment modalities include pharmacological intervention, speech therapy, surgery, deep brain stimulation and vocal fold augmentation. Although management of Parkinsonian dysarthria is clinically challenging, speech treatment in PD should be part of a multidiscipli …
Treatment modalities include pharmacological intervention, speech therapy, surgery, deep brain stimulation and vocal fold augmentatio …
Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia.
Profeta V, McIntyre K, Wells M, Park C, Lynch DR. Profeta V, et al. Expert Opin Investig Drugs. 2023 Jan;32(1):5-16. doi: 10.1080/13543784.2023.2173063. Epub 2023 Feb 8. Expert Opin Investig Drugs. 2023. PMID: 36708320
INTRODUCTION: Friedreich ataxia (FRDA) is a rare autosomal recessive degenerative disorder characterized by ataxia, dysarthria, diabetes, cardiomyopathy, scoliosis, and occasionally vision loss in late-stage disease. ...EXPERT OPINION: The present perspective suggests that …
INTRODUCTION: Friedreich ataxia (FRDA) is a rare autosomal recessive degenerative disorder characterized by ataxia, dysarthria, diabe …
Botulinum toxin as a biological weapon: medical and public health management.
Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. Arnon SS, et al. JAMA. 2001 Feb 28;285(8):1059-70. doi: 10.1001/jama.285.8.1059. JAMA. 2001. PMID: 11209178 Review.
CONCLUSIONS: An aerosolized or foodborne botulinum toxin weapon would cause acute symmetric, descending flaccid paralysis with prominent bulbar palsies such as diplopia, dysarthria, dysphonia, and dysphagia that would typically present 12 to 72 hours after exposure. ...Per …
CONCLUSIONS: An aerosolized or foodborne botulinum toxin weapon would cause acute symmetric, descending flaccid paralysis with prominent bul …
Current evidence on transcranial magnetic stimulation and its potential usefulness in post-stroke neurorehabilitation: Opening new doors to the treatment of cerebrovascular disease.
León Ruiz M, Rodríguez Sarasa ML, Sanjuán Rodríguez L, Benito-León J, García-Albea Ristol E, Arce Arce S. León Ruiz M, et al. Neurologia (Engl Ed). 2018 Sep;33(7):459-472. doi: 10.1016/j.nrl.2016.03.008. Epub 2016 May 6. Neurologia (Engl Ed). 2018. PMID: 27161423 Free article. Review. English, Spanish.
INTRODUCTION: Repetitive transcranial magnetic stimulation (rTMS) is a therapeutic reality in post-stroke rehabilitation. It has a neuroprotective effect on the modulation of neuroplasticity, improving the brain's capacity to retrain neural circuits and promoting restorati …
INTRODUCTION: Repetitive transcranial magnetic stimulation (rTMS) is a therapeutic reality in post-stroke rehabilitation. It has a ne …
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
James E, Ellis C, Brassington R, Sathasivam S, Young CA. James E, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article. Review.
BACKGROUND: Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative condition that may cause dysphagia, as well as limb weakness, dysarthria, emotional lability, and respiratory failure. Since normal salivary produc …
BACKGROUND: Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative condition that …
Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
Park S, Theodoros D, Finch E, Cardell E. Park S, et al. Am J Speech Lang Pathol. 2016 Feb;25(1):97-110. doi: 10.1044/2015_AJSLP-14-0113. Am J Speech Lang Pathol. 2016. PMID: 26882004
PURPOSE: This article describes the effects of a new intensive dysarthria treatment program (Be Clear) on speech intelligibility in adults with dysarthria secondary to stroke and traumatic brain injury. METHOD: A small group-repeated measures research design was use …
PURPOSE: This article describes the effects of a new intensive dysarthria treatment program (Be Clear) on speech intelligibility in a …
Differential diagnostic patterns of dysarthria.
Darley FL, Aronson AE, Brown JR. Darley FL, et al. J Speech Hear Res. 1969 Jun;12(2):246-69. doi: 10.1044/jshr.1202.246. J Speech Hear Res. 1969. PMID: 5808852 No abstract available.
Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.
Drachtman RA, Cole PD, Golden CB, James SJ, Melnyk S, Aisner J, Kamen BA. Drachtman RA, et al. Pediatr Hematol Oncol. 2002 Jul-Aug;19(5):319-27. doi: 10.1080/08880010290057336. Pediatr Hematol Oncol. 2002. PMID: 12078863
Methotrexate-induced neurotoxicity (MTX-Ntox) is a frequent complication of methotrexate (MTX) therapy for patients with both malignant and inflammatory diseases. ...CSF Hcy was higher in these patients (n = 9, median = 0.93 microM) than in asymptomatic patients (n = 11, m …
Methotrexate-induced neurotoxicity (MTX-Ntox) is a frequent complication of methotrexate (MTX) therapy for patients with both maligna …
Primary lateral sclerosis: diagnosis and management.
Turner MR, Talbot K. Turner MR, et al. Pract Neurol. 2020 Aug;20(4):262-269. doi: 10.1136/practneurol-2019-002300. Epub 2020 Mar 26. Pract Neurol. 2020. PMID: 32217663 Review.
The diagnosis is clinical and based on the characteristic features of slowly progressive spasticity beginning in the lower limbs, or more rarely with spastic dysarthria, typically presenting around 50 years of age. The absence of lower motor neurone involvement is consider …
The diagnosis is clinical and based on the characteristic features of slowly progressive spasticity beginning in the lower limbs, or more ra …
176 results